Skip to main content
MorphoSys AG logo

MorphoSys AG — Investor Relations & Filings

Ticker · MOR ISIN · DE000A3H2XW6 LEI · 529900493806K77LRE72 F Manufacturing
Open in API
Filings indexed 1,418 across all filing types
Latest filing 2005-11-22 Interim / Quarterly Rep…
Country DE Germany
Listing F MOR

About MorphoSys AG

https://www.morphosys.com/

MorphoSys AG is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of innovative medicines, primarily for cancer patients. The company specializes in creating therapeutic monoclonal antibodies, utilizing its long-standing expertise and proprietary technology platforms to generate fully human antibodies. Its research and development efforts are concentrated on building a pipeline of novel treatments to address significant unmet medical needs in oncology. In February 2024, Novartis entered into an agreement to acquire MorphoSys, aiming to integrate its antibody technologies and oncology pipeline.

Recent filings

Filing Released Lang Actions
Q3 Report 2005
Interim / Quarterly Report Classification · 100% confidence The document is a 'Nine Months' Financial Report' for MorphoSys Group, covering the period ended September 30, 2005. It contains detailed financial statements (Consolidated Statements of Operations, Balance Sheets, Cash Flows), notes to the financial statements, and a comprehensive management report (MDA) analyzing the financial performance, liquidity, and business operations. Since it covers a period shorter than a full fiscal year and includes substantive financial data, it is classified as an Interim/Quarterly Report. 9M 2005
2005-11-22 English
Q3 Bericht 2005
Interim / Quarterly Report Classification · 100% confidence The document is a 'Nine Months' Financial Report' for MorphoSys Group, covering the period ending September 30, 2004. It contains comprehensive financial statements (Consolidated Statements of Operations, Balance Sheets, Cash Flows), management discussion and analysis, and notes to the financial statements. It is a formal interim report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2004
2005-11-22 English
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the German heading 'Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG' (Notification of transactions by persons discharging managerial responsibilities according to §15a WpHG). It details a 'Verkauf' (Sell) transaction by Dr. Daniel Camus, a member of the board ('Aufsichtsorgan'/'Member of the board'), including the security, date, price, and quantity. This directly corresponds to the definition of Director's Dealing.
2005-11-04 German
Mitteilung uber Geschafte von Fuhrungspersonen nach 15a WpHG
Director's Dealing Classification · 100% confidence The document is explicitly titled 'Directors’ Dealings' and contains the header 'Mitteilung über Geschäfte von Führungspersonen nach §15a WpHG' (Notification of transactions by persons discharging managerial responsibilities under §15a WpHG). It details a transaction (Sale) by a board member ('Gerald Möller', Function: Aufsichtsorgan/Member of the board) involving company shares, including the date, price, and quantity. This directly corresponds to the definition of Director's Dealing.
2005-11-04 German
Q2 Bericht 2005
Interim / Quarterly Report Classification · 100% confidence The document is a 'Halbjahresbericht' (Half-Year Report) for the period ending June 30, 2005, for MorphoSys AG. It contains comprehensive financial statements (Income Statement, Balance Sheet, Cash Flow Statement) and detailed management analysis (Konzernlagebericht). As it covers a period shorter than a full fiscal year and includes substantive financial data, it is classified as an Interim/Quarterly Report. H2 2005
2005-07-28 German
Q2 Report 2005
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Six Months' Financial Report 2005' and covers the period ended June 30, 2005. It contains comprehensive financial statements (Consolidated Statements of Operations, Balance Sheets, Cash Flows), notes to the financial statements, and a detailed management report. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2005
2005-07-28 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.